Depression and inflammation: Correlation between changes in inflammatory markers with antidepressant response and long-term prognosis

Depression heterogeneity and its biological underpinnings: towards immuno-metabolic depression

(2020) Yuri Milaneschi et al.   BIOLOGICAL PSYCHIATRY

Inflammatory Markers in Depression: a Meta-Analysis of Mean Differences and Variability in 5,166 Patients and 5,083 Controls

(2020) Emanuele F. Osimo et al.   BRAIN BEHAVIOR AND IMMUNITY

Prospective study on cytokine levels in medication-naïve adolescents with first-episode major depressive disorder

(2020) Hojun Lee et al.   JOURNAL OF AFFECTIVE DISORDERS

Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder

(2020) Yanni Zhan et al.   Translational Psychiatry

Basal and LPS-stimulated inflammatory markers and the course of individual symptoms of depression

(2020) Wessel A. van Eeden et al.   Translational Psychiatry

Comorbid depression in medical diseases

(2020) Stefan M. Gold et al.   Nature Reviews Disease Primers

Brain-immune crosstalk in the treatment of major depressive disorder

(2020) Igor Branchi et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Longitudinal association between depression and inflammatory markers: results from the NESDA study

(2019) Femke Lamers et al.   BIOLOGICAL PSYCHIATRY

Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis

(2019) Jia Jia Liu et al.   MOLECULAR PSYCHIATRY

Alterations in the Levels of Growth Factors in Adolescents with Major Depressive Disorder: A Longitudinal Study during the Treatment with Fluoxetine

(2019) Enrique Becerril-Villanueva et al.   MEDIATORS OF INFLAMMATION

Using network analysis to examine links between individual depressive symptoms, inflammatory markers, and covariates

(2019) E. I. Fried et al.   PSYCHOLOGICAL MEDICINE

Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder

(2018) Boadie W. Dunlop et al.   JOURNAL OF AFFECTIVE DISORDERS

Cytokine serum levels remain unchanged during lithium augmentation of antidepressants in major depression

(2018) Roland Ricken et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states

(2018) W. Kyle Simmons et al.   MOLECULAR PSYCHIATRY

Effect of antidepressant treatment on peripheral inflammation markers – A meta-analysis

(2018) Magdalena Więdłocha et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Metabolic and inflammatory markers: associations with individual depressive symptoms

(2017) F. Lamers et al.   PSYCHOLOGICAL MEDICINE

White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder

(2016) Ole Köhler et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

A score of low-grade inflammation and risk of mortality: prospective findings from the Moli-sani study

(2016) Marialaura Bonaccio et al.   HAEMATOLOGICA

A score of low-grade inflammation and risk of mortality: prospective findings from the Moli-sani study

(2016) Marialaura Bonaccio et al.   HAEMATOLOGICA

Major depressive disorder

(2016) Christian Otte et al.   Nature Reviews Disease Primers

Inflammation and clinical response to treatment in depression: A meta-analysis

(2015) R. Strawbridge et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Low-grade inflammation predicts persistence of depressive symptoms

(2015) A. Zalli et al.   PSYCHOPHARMACOLOGY

An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline

(2014) Rudolf Uher et al.   AMERICAN JOURNAL OF PSYCHIATRY

The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery

(2014) Johan Dahl et al.   PSYCHONEUROENDOCRINOLOGY

Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life

(2014) Golam M. Khandaker et al.   JAMA Psychiatry

Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors’ and Longitudinal ‘Targets’

(2012) Annamaria Cattaneo et al.   NEUROPSYCHOPHARMACOLOGY

Elevated C-Reactive Protein Levels, Psychological Distress, and Depression in 73 131 Individuals

(2012) Marie Kim Wium-Andersen et al.   JAMA Psychiatry

The role of chemokines and their receptors in angiogenesis

(2011) Friedemann Kiefer et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

The Danish Psychiatric Central Research Register

(2011) Ole Mors et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays

(2009) Wilco de Jager et al.   BMC IMMUNOLOGY

A prospective evaluation of the directionality of the depression–inflammation relationship

(2009) Jesse C. Stewart et al.   BRAIN BEHAVIOR AND IMMUNITY

Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression

(2009) Rudolf Uher et al.   BRITISH JOURNAL OF PSYCHIATRY

Body weight as a predictor of antidepressant efficacy in the GENDEP project

(2009) Rudolf Uher et al.   JOURNAL OF AFFECTIVE DISORDERS

Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder

(2008) María Eugenia Hernández et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study

(2008) D. Gimeno et al.   PSYCHOLOGICAL MEDICINE